MEDVi vs WeightWatchers (Sequence): Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi beats WeightWatchers (Sequence) overall, scoring 7.7/10 vs 7.4/10. WeightWatchers (Sequence) is more affordable at $273/mo vs $299/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose WeightWatchers (Sequence) for users who want glp-1 medication combined with the weightwatc.
A side-by-side comparison of MEDVi and WeightWatchers (Sequence) covering pricing, scores, medication types, insurance, and more to help you decide.
MEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDViWeightWatchers (Sequence)
#25 of 40WeightWatchers' clinical weight management arm (acquired from Sequence) combining GLP-1 medications with WW's iconic points system, community support, and decades of weight loss expertise.
Visit WeightWatchers (Sequence)| Feature | MEDVi | WeightWatchers (Sequence) |
|---|---|---|
| Our Score | 7.7/10 | 7.4/10 |
| Starting Price | $299/mo | $273/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | Yes |
| Best For | Users who want a low entry price with oral and injectable compounded options | Users who want GLP-1 medication combined with the WeightWatchers program and community |
| Ranking | #21 | #25 |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
WeightWatchers (Sequence)
Pros
- +Combines GLP-1 medication with WeightWatchers' proven points system and community support
- +Insurance accepted for medication — can reduce costs significantly with qualifying plans
- +Decades of brand trust and weight loss expertise applied to clinical medication management
- +Access to WW community, workshops, and digital tools alongside medication
Cons
- −$269/mo without insurance is expensive for what's included clinically
- −The WW program integration adds complexity that medication-only users won't value
- −The Sequence acquisition is still integrating — some operational inconsistencies remain
- −Less medication flexibility than pure-play GLP-1 platforms
Our Verdict
MEDVi edges out WeightWatchers (Sequence) with a score of 7.7/10 vs 7.4/10. If budget is your priority, WeightWatchers (Sequence) starts at $273/mo compared to MEDVi's $299/mo. WeightWatchers (Sequence) accepts insurance, which can significantly reduce your out-of-pocket costs. WeightWatchers (Sequence) offers both brand-name and compounded medications, giving you more flexibility. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose WeightWatchers (Sequence) if you want: users who want glp-1 medication combined with the weightwatchers program and community.